Powered by

Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call

Aug 05, 2019 - GlobeNewswire

CAMBRIDGE, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced that it will report its second quarter 2019 financial results and corporate highlights on Friday August 9, 2019 before the open of the U.S. financial markets. Following the announcement, management will host a conference call and live webcast at 8:00 a.m. EDT.